Max Healthcare Institute Limited reported strong Q3 FY25 financial results, showcasing significant growth in revenue and profitability. The company’s revenue from operations increased to Rs 1,868 crore, a 40% year-on-year (YoY) jump compared to Rs 1,335 crore in Q3 FY24. Sequentially, revenue saw an 8% improvement from Rs 1,707 crore in Q2 FY25. Total income for the quarter stood at Rs 1,901 crore, up from Rs 1,381 crore in the same quarter last year.
The company’s total expenses for the quarter rose to Rs 1,519 crore from Rs 1,374 crore in Q2 FY25, driven by higher costs of drugs, employee benefits, and professional consultancy. Profit before tax for the quarter was Rs 309 crore, compared to Rs 360 crore in Q2 FY25. Net profit for the quarter stood at Rs 239 crore, slightly down from Rs 281 crore in the previous quarter but showing consistent overall growth compared to Rs 289 crore in Q3 FY24.
Key expense components included the purchase of drugs and consumables, which stood at Rs 397 crore, and employee benefits at Rs 305 crore, reflecting investments in operational expansion and service delivery. Depreciation expenses for the quarter increased to Rs 97 crore compared to Rs 61 crore YoY.
Max Healthcare’s strong performance highlights its robust growth trajectory, driven by an expansion in medical services and optimized cost management strategies.
Key Financial Highlights:
- Revenue from operations: Rs 1,868 crore (up 40% YoY from Rs 1,335 crore, up 8% QoQ from Rs 1,707 crore)
- Total income: Rs 1,901 crore (up 38% YoY from Rs 1,381 crore)
- Total expenses: Rs 1,519 crore (up from Rs 1,021 crore YoY and Rs 1,374 crore QoQ)
- Profit before tax: Rs 309 crore
- Net profit: Rs 239 crore (compared to Rs 281 crore in Q2 FY25 and Rs 289 crore YoY)
With sustained growth across its healthcare segments, Max Healthcare aims to continue its strategic expansion while ensuring quality service delivery and cost control.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
